Cases 21 - 30 of 92
Eli Lilly and Company et al v. Par Pharmaceutical, Inc. et al
as 1:2017cv00456
Plaintiff:
Eli Lilly and Company , Eli Lilly Export S.A. and Acrux DDS Pty Ltd.
Defendant:
Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc.
Cause Of Action: 35 U.S.C. § 271
Shire-NPS Pharmaceuticals, Inc. v. Ambio, Inc. et al
as 1:2017cv00397
Plaintiff:
Shire-NPS Pharmaceuticals, Inc.
Defendant:
Ambio, Inc. , AmbioPharm, Inc. , Par Pharmaceutical Companies, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Par Pharmaceutical, Inc.
as 1:2017cv00342
Plaintiff:
Pfizer Inc. , Pfizer Limited and Pfizer Ireland Pharmaceuticals
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Par Pharmaceutical, Inc. et al
as 1:2017cv00040
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Par Pharmaceutical, Inc. , Par Pharmaceutical Companies, Inc. and Par Formulations Private Limited
Cause Of Action: 35 U.S.C. § 271
Aptalis Pharma Canada ULC et al v. Par Pharmaceutical, Inc.
as 1:2016cv01069
Plaintiff:
Aptalis Pharma Canada ULC, Forest Laboratories, LLC and Allergan USA, Inc.
Defendant:
Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
United Therapeutics Corporation v. Par Sterile Products, LLC et al
as 1:2016cv01066
Plaintiff:
United Therapeutics Corporation
Defendant:
Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc.
Cause Of Action: 35 U.S.C. § 271
IMPAX Laboratories, Inc. et al v. Par Pharmaceutical Inc.
as 1:2016cv00856
Plaintiff:
IMPAX Laboratories, Inc. , AstraZeneca AB and AstraZeneca UK Limited
Defendant:
Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Cosmo Technologies Limited et al v. Par Pharmaceutical, Inc.
as 1:2015cv01049
Plaintiff:
Cosmo Technologies Limited , Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.A.R.L.
Defendant:
Par Pharmaceutical, Inc.
Counter_claimant:
Par Pharmaceutical, Inc.
Counter_defendant:
Cosmo Technologies Limited , Valeant Pharmaceuticals International and Valeant Pharmaceuticals Luxembourg S.A.R.L.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.
as 1:2015cv01050
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Par Pharmaceutical Inc.
Counter_claimant:
Par Pharmaceutical Inc.
Counter_defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc.
as 1:2015cv01039
Plaintiff:
Par Pharmaceutical Inc. and Alkermes Pharma Ireland Limited
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
